Ãå±±½ûµØ

close

TAGGED : cancer

GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023

ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 3, 2023--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial results and highlights for the third quarter ...